Recordati profit up

Recordati first-half core profit rises 8.8% on rare diseases

Italian drugmaker Recordati reported an 8.8% rise in first-half core profit to €540.2 million, driven by its rare diseases segment. Its board deemed a €10.7 billion takeover offer fair, despite dissen